DEA issues first medical marijuana dispensary registrations, including in Florida, opening door to tax relief

The U.S. Drug Enforcement Administration has issued its first federal registrations to state-licensed medical marijuana dispensaries, and Florida is one of seven states included in the initial batch, the Justice Department announced Friday, Oct. 30. The move puts Florida's medical marijuana industry, one of the largest in the nation, a step closer to federal tax treatment that operators have sought for years.

The Justice Department said the initial registrations cover more than 900 dispensaries across Alabama, Florida, Mississippi, South Dakota, Texas, Virginia and West Virginia. The department did not identify the approved businesses or say how many of them are in Florida.

What the DEA approved

The registrations are the first phase of carrying out an order Attorney General Todd Blanche signed on April 23 under the Controlled Substances Act. That order moved qualifying state-licensed medical marijuana activities from Schedule I, the category reserved for drugs considered to have no accepted medical use and a high potential for abuse, to the less restrictive Schedule III. It also set up a federal registration framework for medical marijuana businesses.

According to the Justice Department release, each dispensary had to pass a DEA pre-registration investigation before receiving a registration, and the agency began with dispensaries that applied within the initial 60-day window the order created. The department stressed that state licensure alone does not automatically grant federal registration. Registered dispensaries will be subject to federal requirements for security, recordkeeping, inventory controls and other safeguards that apply to handling controlled substances.

"The regulated distribution of medical marijuana by the applicants that have been granted registration by the Drug Enforcement Administration will help ensure broader access to chronic pain treatment and the safety of the American people," Blanche said in the release. He added that the department will continue prosecuting illegal marijuana trafficking.

The DEA is still processing other dispensary applications and is separately reviewing applications from manufacturers and distributors, which the department said require additional review including facility inspections, production controls and quota determinations. Nearly 7,000 dispensaries, manufacturers and distributors nationwide have applied, according to a list the DEA published Friday, The Associated Press reported.

Under the order, qualifying businesses that applied within the 60-day window and whose applications are still pending may continue medical marijuana transactions with other qualified applicants and registered entities while they wait.

Why the tax question matters

The biggest financial stake for businesses is Section 280E of the Internal Revenue Code. The provision bars businesses that traffic in Schedule I or Schedule II controlled substances from deducting ordinary business expenses on their federal returns. Because marijuana was a Schedule I drug, state-licensed cannabis companies have not been able to deduct costs such as rent, advertising or labor tied to sales, the AP reported, a burden many in the industry have described as financially crippling.

Moving medical marijuana to Schedule III takes it outside the reach of 280E. Registration with the DEA is expected to help secure those tax benefits for medical operators, according to the AP.

The stakes are visible in the books of Florida's largest operator. Tallahassee-based Trulieve, which describes itself as the largest medical cannabis retailer in the United States, said in its most recent quarterly filing with the Securities and Exchange Commission that it applied to register all of its state-licensed medical operations with the DEA in Florida, Georgia, Pennsylvania and West Virginia after the April rescheduling, and that it has been working with the agency to complete site inspections. The company said its operations are deemed federally lawful while its applications are reviewed.

Trulieve reported $598.2 million in net uncertain tax position liabilities as of June 30, of which $583.1 million relates to its position that 280E does not prevent it from deducting ordinary business expenses. In the same filing, the company said it concluded that its tax positions for its state-licensed medical operations meet the accounting recognition threshold for the 2026 tax year, and it recorded no new uncertain tax position for that year. Trulieve operated 169 dispensaries and five cultivation and processing facilities in Florida as of June 30, according to the filing.

Florida's medical marijuana market

Florida voters approved medical marijuana in 2016 with Amendment 2, which received about 71% of the vote. The program is overseen by the Florida Department of Health's Office of Medical Marijuana Use. State figures reported this year put the number of qualified patients at more than 930,000, and the number of approved dispensing locations has climbed past 750, according to weekly state data reported by The Marijuana Herald.

Florida's system is vertically integrated: licensed medical marijuana treatment centers grow, process and sell their own products through their own dispensaries. That structure means a single DEA framework for growers, processors and retailers could touch every part of a Florida company's operations, though for now only dispensaries have received registrations.

Florida's market is medical-only. In 2024, a proposed constitutional amendment to legalize adult recreational use, Amendment 3, won a majority but fell short of the 60% required to pass. That matters under the new federal framework: the Justice Department said its order covers only qualifying medical activities and does not authorize recreational marijuana. Marijuana outside the order's scope remains a Schedule I substance.

Reaction and open questions

Steph Sherer, founder of the advocacy group Americans for Safe Access, said in a statement quoted by the AP that "for the first time, the federal government is recognizing and registering the medical cannabis dispensaries that patients fought to establish."

Chris Lindsey, vice president of policy and state advocacy at the American Trade Association for Cannabis and Hemp, told the AP it is "obviously a positive step to see the program taking shape," while noting the industry is watching to see what the new obligations will look like in practice.

Significant questions remain. State-licensed medical marijuana businesses are regulated very differently from the pharmaceutical companies that typically handle Schedule III drugs, and it is unclear exactly what requirements the DEA will impose, the AP reported. Some cannabis attorneys have noted that state regulators often allow people with certain criminal histories to work in licensed businesses, and it is not certain the DEA will take the same approach. It also remains unclear how the agency will treat businesses that handle both medical and adult-use cannabis in states that have merged those markets.

What it means for Florida patients

For the roughly 930,000 Floridians in the state program, the immediate change is less visible than it is for businesses. Patients will still need a qualified physician's certification and a state registry card, and Florida's rules on qualifying conditions, purchase limits and product forms are unaffected by the DEA action. Federal registration does bring federal security and recordkeeping obligations for dispensaries, which could change how some stores operate behind the counter.

Whether lower federal tax bills translate into lower prices for patients will depend on the companies.

What's next

The DEA said it will keep issuing registrations to qualifying dispensaries in phases and continue reviewing manufacturer and distributor applications. A broader proposed rescheduling of marijuana, which would reach beyond medical activities, is being handled in a separate administrative proceeding under the Controlled Substances Act, the Justice Department said.

Florida operators and investors will be watching for the DEA's decisions on cultivation and processing applications, which matter most in a vertically integrated state, and for the first full tax year in which medical operators file without 280E's restrictions. Companies such as Trulieve are also continuing to contest 280E liabilities from earlier years, which the rescheduling does not erase.